Ulrik Svane Sørensen
Fondateur chez Acesion Pharma ApS
Postes actifs de Ulrik Svane Sørensen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Acesion Pharma ApS
 Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Fondateur | 01/01/2011 | - |
| Directeur des opérations | 01/01/2016 | - | |
| Directeur Général | 01/01/2011 | 01/01/2016 |
Historique de carrière de Ulrik Svane Sørensen
Formation de Ulrik Svane Sørensen
| Copenhagen Business School | Doctorate Degree |
Statistiques
Internationale
| Danemark | 3 |
Opérationnelle
| Chief Executive Officer | 1 |
| Chief Operating Officer | 1 |
| Founder | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Acesion Pharma ApS
Acesion Pharma ApS Pharmaceuticals: MajorHealth Technology Acesion Pharma ApS develops drugs for the treatment of atrial fibrillation (AF), the most common type of cardiac arrhythmia. The firm's technology blocks ion channel with a selective drug molecule constitutes a target for developing treatment of AF. The company was founded by Ulrik Svane S?rensen and Morten Grunnet in 2011 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Bourse
- Insiders
- Ulrik Svane Sørensen
- Expérience
